Anatara Lifesciences Ltd (ANR) — Cash Flow-to-Debt Ratio
Anatara Lifesciences Ltd (ANR) has a Cash Flow-to-Debt Ratio of -2.24x as of June 2025, meaning its operating cash flow of AU$-1.37 Million could theoretically repay -2% of its total liabilities (AU$612.42K) in one year. Check Anatara Lifesciences Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anatara Lifesciences Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Anatara Lifesciences Ltd across 13 annual periods. Also explore total assets of Anatara Lifesciences Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Anatara Lifesciences Ltd (2013–2025)
Year-by-year debt coverage analysis for Anatara Lifesciences Ltd. For market capitalisation and broader financial context, see Anatara Lifesciences Ltd (ANR) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.71x | AU$-2.27 Million | AU$612.42K | ▲ +8.7% |
| 2024 | -4.07x | AU$-1.25 Million | AU$306.85K | ▲ +10.9% |
| 2023 | -4.56x | AU$-2.26 Million | AU$494.83K | ▲ +17.6% |
| 2022 | -5.54x | AU$-2.23 Million | AU$403.35K | ▼ -31.1% |
| 2021 | -4.22x | AU$-2.10 Million | AU$496.67K | ▲ +24.5% |
| 2020 | -5.60x | AU$-2.72 Million | AU$486.96K | ▼ -16.7% |
| 2019 | -4.79x | AU$-2.24 Million | AU$466.76K | ▼ -77.1% |
| 2018 | -2.71x | AU$-3.32 Million | AU$1.22 Million | ▲ +72.2% |
| 2017 | -9.74x | AU$-2.88 Million | AU$295.44K | ▼ -1445.1% |
| 2016 | -0.63x | AU$-280.37K | AU$444.62K | ▲ +95.2% |
| 2015 | -13.09x | AU$-1.92 Million | AU$146.98K | ▼ -366.2% |
| 2014 | -2.81x | AU$-639.27K | AU$227.62K | ▼ -459.4% |
| 2013 | -0.50x | AU$-177.22K | AU$352.96K | — |